ACT 2 Logo
TREATMENT · BETA BLOCKERS · SAFETY

Beta Blockers With Asthma, Diabetes or Low Blood Pressure

Beta blockers are old, cheap and well understood, and their exclusion list is correspondingly precise. The main page gives it in a line: asthma, a slow resting heart rate, certain rhythm problems, low blood pressure. This page is the mechanism behind each item — why it is there, how absolute it is, and what a person who sits near the line should tell us — plus one interaction that matters more on this site than most, because so many of our patients are on a GLP-1 or metformin.

See if you're eligibleA short, confidential online assessment. Reviewed by a clinician.
Medically reviewed by Benjamin H. Krasne, M.D. September 15, 2026

What a beta blocker blocks

Adrenaline and noradrenaline act on two families of receptor. Beta-1 receptors sit mainly on the heart, where the signal speeds it up and makes it pump harder. Beta-2 receptors sit mainly on the airways, where the signal opens them, and on blood vessels and the liver, where it has metabolic effects. A non-selective beta blocker such as propranolol blocks both families. A cardioselective one — metoprolol, atenolol, bisoprolol — blocks mostly beta-1 at ordinary strengths, with the selectivity fading as the amount rises.

Every exclusion on this page follows from one of those two receptors.

Asthma: the absolute one

Beta-2 stimulation is what keeps the airways open, and it is precisely what an asthma rescue inhaler delivers. A non-selective beta blocker does the opposite: it blocks the receptor the airways depend on, can provoke bronchospasm in someone with reactive airways, and — worse — blunts the rescue inhaler's ability to reverse it. Deaths have been reported. Propranolol and asthma is a contraindication on the label, not a caution, and no situational benefit for a presentation justifies it.

Cardioselective agents are less dangerous but not safe: selectivity is relative, and asthma guidelines still advise caution or avoidance. A history of childhood asthma that has been quiet for decades, or of wheezing only with chest infections, sits in a gray area where the clinician needs the detail. COPD is a related caution with a more nuanced literature. The rule for our purposes is simple: any history of asthma or reactive airway disease is disclosed at assessment, and non-selective beta blockers are not prescribed to anyone with it.

Diabetes and hypoglycemia: the masked one

When blood sugar falls, adrenaline is part of the alarm: it produces the tremor, the racing heart, the sweating and the anxiety that tell a person to eat. A beta blocker mutes most of that. The sweating persists, but the heart-rate and tremor warnings — the ones people rely on — are gone, and a hypoglycemic episode can progress to confusion before it is noticed. Non-selective agents also slow recovery from a low, because beta-2 receptors in the liver help release stored glucose.

This is a labeled warning for people with diabetes on insulin or sulfonylureas, who are the people who go hypoglycemic. It is relevant here because so many of our patients take a GLP-1 or metformin, and the question the main page's FAQ raises deserves a fuller answer: neither drug on its own causes hypoglycemia in a person without diabetes — that is a well-established property of both — so the masking effect is not the concern it is with insulin. The concern is the person with diabetes on one of them alongside insulin or a sulfonylurea, or the person eating very little on a GLP-1 and exercising hard, whose glucose can drop for ordinary reasons. Both need to know that the usual warnings will be muted.

A slow pulse or a conduction problem: the electrical one

A beta blocker slows the heart. In a person whose resting rate is already slow — a well-trained endurance athlete, an older adult, someone on another rate-slowing drug — it can slow it to the point of dizziness, fainting or worse. And in a person whose heart's electrical conduction is already impaired (second- or third-degree heart block, sick sinus syndrome), a beta blocker can block it further. These are labeled contraindications, and they are the reason a resting heart rate and, where indicated, an ECG come before the prescription rather than after.

Athletes are the group most often surprised by this. A resting rate in the forties is a badge of fitness and a reason a beta blocker may not be for you; the athletes page covers the broader question.

Low blood pressure: the obvious one

Beta blockers lower blood pressure. A person whose pressure is already low, or who is already on blood-pressure medication, or who faints on standing, is a person for whom the added fall may be too much. The specific interaction with PDE5 inhibitors is on that page; alpha-blockers for the prostate, diuretics and every antihypertensive add to the effect. This is a caution rather than an absolute exclusion, and it is managed by knowing the numbers and the medication list before starting.

The others

Severe peripheral arterial disease or Raynaud's, which beta blockers can worsen. Untreated phaeochromocytoma, where a beta blocker alone can provoke a crisis — rare, and screened by the history. Pregnancy and breastfeeding, where the calculus changes and a situational beta blocker is generally not worth it. Depression, where propranolol has a weak historical association that the evidence does not strongly support but that is worth knowing about. And, on the other side of the ledger, thyroid overactivity — where a beta blocker is often used to control the racing heart, and where a person asking for one for "nerves" may have a thyroid problem instead. The main page's FAQ on a racing heart being something other than anxiety is the right link.

One more, which is a rule about stopping rather than starting: a beta blocker taken regularly must not be stopped abruptly, because the heart's receptors have upregulated and rebound tachycardia, blood-pressure surges and — in people with coronary disease — angina or worse can follow. Situational use, a tablet before an event, does not produce this. Regular use does, and the main page FAQ on stopping is worth reading before the first regular tablet.

Questions

Frequently asked questions

  • No. Propranolol is non-selective and blocks the airway receptor that asthma inhalers act on; it can provoke bronchospasm and blunt the rescue inhaler. Asthma is a contraindication on the label.

  • They mask the warning signs of hypoglycemia — tremor, racing heart — and non-selective agents slow recovery from a low. This matters for people with diabetes on insulin or sulfonylureas; GLP-1s and metformin do not cause hypoglycemia on their own in people without diabetes.

  • Usually, if nothing else on this page applies. The masking effect matters if you also take insulin or a sulfonylurea, or if you are eating very little and exercising hard.

  • A resting rate in the forties or fifties — common in endurance athletes — is a reason a beta blocker may slow it too far. Rate and, where indicated, an ECG are checked before prescribing.

  • Sometimes, with the numbers and the full list known. Every antihypertensive, alpha-blocker and PDE5 inhibitor adds to the pressure-lowering effect.

  • A single situational tablet, yes. A beta blocker taken regularly, no — abrupt stopping causes rebound heart rate and blood pressure and, in people with heart disease, can be dangerous.

Your next step

Where this fits in your plan

The Beta Blockers page covers what they do and who they suit; this page is the list that decides it. Resting heart rate, blood pressure and the medication list are on the assessment for exactly these reasons.

We measure first. Then we act.

References

  1. Propranolol hydrochloride prescribing information — contraindications (bronchial asthma, sinus bradycardia, heart block, cardiogenic shock), warnings (diabetes and hypoglycemia, abrupt cessation).
  2. Morales DR et al. Adverse respiratory effect of acute β-blocker exposure in asthma: a systematic review and meta-analysis of randomized controlled trials. Chest 2014;145:779–786.
  3. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention, current edition — β-blocker guidance.
  4. Cryer PE. Hypoglycemia-associated autonomic failure in diabetes. American Journal of Physiology — Endocrinology and Metabolism 2001;281:E1115–E1121.
  5. Frishman WH. β-Adrenergic blockade withdrawal. American Journal of Cardiology 1987;59:26F–32F.
  6. Nauck MA et al. GLP-1 receptor agonists in the treatment of type 2 diabetes — state-of-the-art. Molecular Metabolism 2021;46:101102 — hypoglycemia risk profile.

How we write and review our content

ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.

All medical decisions are made solely by licensed healthcare professionals. Medications are prescribed only when medically necessary. GLP-1 medications are not suitable for everyone. Results may vary.

Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.

Wheezing or breathlessness after taking a beta blocker is an emergency — use your rescue inhaler and call 911.

We measure first. Then we act.

Start with a baseline. Then decide about beta blockers.